Home > Income Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Revenue

    Back to Income Statement
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹198 Cr₹154 Cr₹140 Cr₹114 Cr₹69 Cr

What is the latest Revenue of KILITCH DRUGS (INDIA) ?

The latest Revenue ratio of KILITCH DRUGS (INDIA) is ₹198 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹198 Cr
Mar2024₹154 Cr
Mar2023₹140 Cr
Mar2022₹114 Cr
Mar2021₹69 Cr

How is Revenue of KILITCH DRUGS (INDIA) Trending?

Years Revenue % Change
Mar2025 ₹198 Cr
28.47
Mar2024 ₹154 Cr
10.58
Mar2023 ₹140 Cr
22.20
Mar2022 ₹114 Cr
66.71
Mar2021 ₹69 Cr -

Compare Revenue of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹611.3 Cr 0.2% -4.1% -24.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹468,842.0 Cr -0.4% 4.3% 13.6% Stock Analytics
DIVIS LABORATORIES ₹193,860.0 Cr 0.9% 8.9% 8% Stock Analytics
TORRENT PHARMACEUTICALS ₹192,687.0 Cr 0.7% 13% 46.5% Stock Analytics
CIPLA ₹112,593.0 Cr -1% -0% -3.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,364.9 Cr -3.3% -8.4% -4.3% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

0.2%

-4.1%

-24.3%

SENSEX

-1%

-0.9%

-7.5%


You may also like the below Video Courses